Skip to main content
. 2017 Jan 30;16:13. doi: 10.1186/s12943-016-0571-x

Fig. 1.

Fig. 1

Leukemia stem cells in AML. Transforming mutations in hematopoietic stem cells (HSC) and/or common myeloid progenitor (CMP) leads to the formation of leukemia stem cells (LSCs), which have mutations in survival signaling pathways and altered self renewal capacity. Chemotherapy can significantly abolish the AML blast cells population while the LSCs survive, and instigate relapse in the future